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It is indeed an honor to have been invited to
give the Annual Herman Beerman Lecture this
year on stress and calciphylaxis in their relation-
ship to dermatology. Throughout my research
career I have been chiefly interested in the vary-
ing degrees of biologic specificity. This approach
to physiology led me to formulate the concept of
stress as the most nonspecific biologic reaction-
form to any kind of stimulation or damage and
to recognize the general adaptation syndrome
(G.A.S.) and the local adaptation syndrome
(L.A.S.) as the prototypes of systemic and topical
nonspecific reactions, respectively.
Now, my associates and I are chiefly engaged
in the clarification of a new biologic reaction-
form which we named "calciphylaxis." Calci-
phylaxis is more specific than the stress responses
both as regards the agents that elicit it and the
target regions that respond; yet, calciphylactic
reactions share certain cardinal features with the
stress responses: they are elicited by numerous
agents and they primarily affect the almost
ubiquitous connective tissue and stromal ele-
ments. These, unlike the so-called "noble ele-
ments" of parenchymal tissues, are diffusely
distributed throughout the body and, hence, well
placed to regulate those general reactions of the
body that govern physiologic and pathologic
responses affecting the organism as a whole.
Perhaps the most characteristic feature of
stress reactions is inflammation with its corollary,
the "collagen diseases," whereas calciphylaxis is
primarily characterized by calcification. The fact
that inflammation is a connective-tissue reaction
requires no comment, but it is well to point out
that the same is essentially true of calcification:
the principal physiologic site of calcification
in the body is the collagen of bones, and even
pathologic soft-tissue calcification—especially
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as it occurs in calciphylaxis—affects primarily
the connective-tissue elements. Since the skin
consists mainly of connective tissue, it is not
unexpected that both stress and calciphylaxis
play a particularly important role in dermatology.
The concept of stress and the stress-induced
"diseases of adaptation" has been described at
length in several monographs (5—7), and even its
particular dermatologic implications have been
the subject of several reviews (1—4); hence,
we need not deal with these topics exhaustively
here. Recently, there also appeared a systematic
treatise on calciphylaxis (5) but, since this subject
is still comparatively new, we shall have to out-
line its essential features before turning our
attention to the many interesting relationships
between nonspecific stress, calciphylactic re-
activity, and the physiopathology of the skin.
BRIEF CHARACTERIZATION OF CALcIPHYLAxI5
Definition.—Calciphylaxis is a condition of
induced systemic hypersensitivity in which
tissues respond to appropriate challenging agents
with local calcification.
The term was coined in analogy with such
designations as anaphylaxis, tachyphylaxis, or
skeptophylaxis that likewise refer to induced
systemic alterations in the body's responsiveness.
Apparently, calciphylaxis is a fundamentally
defensive (phylactic) response which, depending
upon circumstances, can either produce calcifica-
tion by concentrating calcium salts in more
or less circumscribed foci, or prevent calcinosis
by "deviation" or dispersion of the metal
throughout the body. The concentrating form of
calciphylaxis often provokes inflammation and
sclerosis through the selective deposition of ir-
ritating calcium salts in the challenged area;
it can thereby help sequestrate a pathogen with
granuloma tissue, thus increasing resistance to
topical injury. However, this focal form of
ealciphylaxis can also become the cause of morbid
lesions if an excessive amount of mineral is
deposited in the tissues. Deviating calciphylaxis,
on the other hand, can interfere with the most
varied forms of focal calcification by dispersing
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calcium to innumerable minute turnover points
throughout the body; here, no major unabsorb-
able mineral deposit is formed and any excess of
calcium is readily metabolized.
Among the concentrating forms we distinguish:
1) topical calciphylaxis induced by the direct
application of the challenger to the responsive
tissue, from
2) systemic calciphylaxis in which the chal-
lenger is distributed throughout the organism
(e.g., after intravenous or intraperitoneal ad-
ministration), but produces a response only in
tissues for which it has a selective affinity.
Conversely, deviating calciphylaxis is induced
by gradually saturating the organism with a
readily diffusible challenger, for example, with
ferric dextran, or "Fe-Dex." When given in this
manner, the challenging iron atoms are dispersed
throughout the body into the connective-tissue
elements, particularly the phagocytes and, since
all the minute iron foci attract calcium, they
compete for it. As a consequence of this competi-
tion, calcium is fairly evenly distributed through-
out the organism and circumscribed, massive
soft-tissue calcifications cannot occur.
CONCENTRATING CALCIPHYLAXIS
Exam ples.—If a rat (weighing about 100 g.) is
given a single oral dose of dihydrotachysterol,
or "DHT" (e.g., 1 mg. in 0.5 ml. of corn oil), the
subcutaneous injection of as little as 25 zg. of
FeC13 (in 0.2 ml. of water) on the following day
elicits a precipitous local deposition of calcium
salts within the next two to three days. Macro-
scopically, this topical calciphylactic response is
characterized by the appearance of a hard white
patch at the site of injection. Histologically, we
note calcareous incrustation of dermal and sub-
cutaneous connective-tissue fibers, followed by
reactive inflammatory infiltration (in which
eosinophils and pseudoesosinophils predominate)
and eventually sclerosis.
If under similar circumstances, instead of the
subcutaneous application of FeC13, 1 ml. of a
ferric oxide saccharate, or "Fe-OS" (containing
20 mg. of metallic iron), is injected intravenously
on the day of sensitization with DHT, a systemic
calciphylactic syndrome results. Here, calcification
occurs predominantly in the left auricular ap-
pendage of the heart, the subepicardial layers of
the ventricular myocardium, the bile ducts, the
duodenum and the renal cortex. Presumably,
this distribution is due to the fact that iron, when
given in this form, tends to accumulate selectively
in these regions and attracts calcium to them.
As we shall see, there are many other sen-
sitizers, or "systemic calcifiers," that can replace
DHT, and numerous challengers can substitute
for FeC13 or Fe-OS in the production of such
calciphylactic responses; yet, almost invariably
the interval elapsing between the application of
the systemic sensitizer and the local challenger is
of decisive importance. In the examples of topical
and systemic calciphylaxis just mentioned, the
"critical period" for the most efficacious applica-
tion of the challenger happens to be respectively,
24 hours and 0 hour after sensitization; however,
the length of this interval varies, depending upon
the sensitizers and the challengers used. Indeed,
some types of calciphylaxis can only be obtained
by applying the challenger before the sensitizer,
and even the quality of the response (e.g., the
distribution of the lesions in systemic calciphy-
laxis) may depend upon the timing of the two
types of pathogens.
Both topical and systemic calciphylaxis are
truly pluricausal morbid lesions, since in them-
selves neither the sensitizing DHT nor the chal-
lenging iron preparations can evoke them.
THE CALCIFIER (SYSTEMIC SENsITIZING AGENT)
Most of the original work on calciphylaxis was
performed on animals sensitized with DHT, a
readily available and extremely active, calcifica-
tion-promoting agent whose actions are essenti-
ally those of parathyroid hormone.
Degranulalion of mastocyles induced by DHT.—Intense degranulation of mastocytes is seen following
chronic treatment with DIIT, both in the otherwise untreated (top) and in the Fe-Dex-protected (mid-
dle and bottom) rats. Following Fe-Dex treatment, however, the iron granules are closely intermixed
with the discharged metachromatic mastocyte granules. Top: Virtually fat-free skin of rat treated
with Fe-Dex alone. There are numerous mastocytes around the cutaneous vessels, but all of them have
discharged their metachromatic (purple) granules (cresyl violet, X 420). Middle: Corresponding skin
lesion of a Fe-Dex-protected rat shows well developed fat tissue, but the mastocytes around vessels
and nerves nevertheless discharged their granules (purple). The latter are intermixed with the iron
granules, which are yellowish-green because unstained (cresyl violet, X 420). Bottom: Small blood
vessel in the cutaneous muscle of a DHT + Fe-Dex-treated rat. Here, the iron granules are stained
blue, while the mastocyte granules are again metachron-iatically purple. Note close topographic rela-
tionships between the two types of granules (Prussian blue plus cresyl violet, X 420).
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We still do not know how calciphylactic sen-
sitization acts, but all sensitizers tested share
with DHT the property of mobilizing calcium
and predisposing for calcification in general;
that is why these agents may also be referred to
simply as calcifiers. However, the nonspecific
"metastatic" calcification caused by a mere
excess of such calcifiers (without the need for
additional treatment with an exogenous chal-
lenger) differs essentially from calciphylaxis in
that it occurs only in certain naturally pre-
disposed sites (e.g., gastric mucosa, cardiovascu-
lar system, kidney). Hence calcification thus
produced—e.g., by excessive amounts of para-
thyroid hormone or DHT, alone—offers no
possibility of altering the distribution pattern of
the resulting lesions by directing calcium at will
to predetermined sites.
Among the calciphylactic sensitizers examined
to date, vitamin D2, vitamin D3, parathyroid
hormone and sodium acetylsulfathiazole (NaAST)
have also proven to be very effective. Under
appropriate conditions of dosage and timing
pretreatment with any of these compounds
"conditions" for the induction of a precipitous
local calcification of the connective-tissue fibers
(followed by sclerosis or even necrosis) at sites
subsequently treated with challengers (e.g.,
FeCl3). Of course, when given in very high doses,
any of these calcifiers can produce nonspecific
calcinosis at the previously mentioned sites of
predisposition, but even at much lower doses they
sensitize other tissues for calcification under the
influence of challenge.
The vitamin-D compounds are close chemical
analogues of DHT; like the latter, they appear
to act directly and not through stimulation of
parathyroid-hormone secretion, since they remain
effective even after parathyroidectomy. On the
other hand, NaAST acts as a calcifier only in the
presence of the parathyroids.
The possibility of producing ealciphylaxis with
NaAST shows that this response can be elicited
by autologous parathyroid hormone in the
amounts secreted as a consequence of renal dam-
age.
Even various surgical interventions (e.g.,
bilateral nephrectomy, ligature of both ureters,
obstruction of the pylorus combined with the
establishment of a gastric fistula) can produce
metastatic calcification at the usual sites of
predisposition. Presumably the effect of these
operations is also mediated through parathyroid
stimulation, since it is abolished by parathyroi-
dectomy. Yet, all these interventions are only
moderately effective sensitizers, perhaps because
they produce intense stress and an alarm reaction
tends to prevent calciphylaxis.
Thus we have learned to distinguish between
direct systemic calciflers that sensitize for calci-
phylaxis in themselves and indirect systemic
calciflers whose action depends upon a secondary
reaction, the increased elaboration of an endog-
enous sensitizer (e.g., parathyroid hormone).
Many drugs can cause "dystrophic calcification"
without any special sensitization by virtue of
their destructive action upon certain organs that
are naturally predisposed to take up calcium;
yet, these drugs do not necessarily sensitize for
calciphylaxis. For example, intoxication with
HgC12 causes severe calcification of the renal
tubules damaged by mercury, but fails to sensi-
tize other tissues to the calciphylactic action of
potent challengers. Other compounds, the "direct
calcifiers" (e.g., Phd2, CeCl3, ZnCh, KMnO4)
can produce local calcification anywhere in
connective tissue without the need for sensitiza-
tion, although they are much less damaging than
certain irritants and corrosives (e.g., croton oil,
HCl, NaOH) that cause no topical calcinosis.
Apparently there exist essential differences
between dystrophic calcification, direct calcifica-
tion and calciphylaxis.
We have already mentioned that some sensi-
tizers act directly, others indirectly, (e.g., through
parathyroid stimulation). A similar distinction
may be made as regards the challengers. Most of
these act at the site of application; for example,
they produce cutaneous calcinosis wherever they
are subcutaneously injected in a DHT-sensitized
rat. Among these direct challengers are salts of
iron, chromium, aluminum, manganese, thorium,
cerium, zirconium, titanium and lead; but certain
organic compounds (e.g., egg white, egg yolk)
and even the mild mechanical trauma of plucking
the hair or pinching the skin are also very effective
in this respect.
Here again—as with the direct calcifiers—there
appears to be no proportionality between the
damaging effect of an agent (as judged by its
ability to cause necrosis or inflammation) and
its calcifying action: many strong inflammatory
irritants and corrosives are quite ineffective,
while typical challengers produce calciphylactic
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responses even at dose levels at which by them-
selves they elicit no demonstrable tissue-damage.
Most of the direct challengers that cause topical
calciphyläxis upon subcutaneous injection also
proved to elicit a systemic calciphylactic syn-
drome when administered intravenously or
intraperitoneally. However as we shall see, the
distribution and structure of the resulting lesions
differ greatly, depending upon the particular
organ affinities of the various challengers and
upon the reactivity of the experimental animal.
For example, in rats sensitized with DHT, the
intravenous administration of egg white pro-
duces an almost selective calcification of the
skin and pancreas, whereas egg yolk causes
calcification in the spleen and the Kupffer cells
of the liver (presumably because the yolk globules
tend to be phagocytosed by the cells of the
RES). Both these systemic ealeiphylactie reac-
tions are, in turn, quite unlike that produced
under similar circumstances by Fe-OS, which
we have already discussed. Factors affecting the
reactivity of the organism (e.g., age, genetic
background, hypophysectomy, drugs, stress)
can likewise markedly alter the intensity and
quality of ealeiphylactie responses.
Indirect challengers are agents that cause little
or no topical ealeiphylaxis when directly applied
to an otherwise receptive site, such as the skin
of a suitably sensitized animal, but elicit systemic
ealeiphylaetic syndromes when introduced into
the general circulation. For example, in the DHT-
sensitized rat histamine liberators (e.g., 48/80,
dextran, polymyxin, glucocorticoids) cause virtu-
ally no local cutaneous calcinosis upon subcuta-
neous administration, but they can elicit calci-
phylactic responses in various distant organs if
injected intravenously or intraperitoneally.
Indeed, if sufficiently large amounts of such
compounds are injected subcutaneously, systemic
ealciphylaxis may result even though the site of
administration fails to undergo calcification. As a
working hypothesis, we assume that compounds
of this type act only indirectly through the libera-
tion or activation of some endogenous challenger
(e.g., mastocyte granules, iron).
THE ADJUVANT (TOPICAL ACTIVATOR OF
CHALLENGER)
Certain substances that have little or no
challenging action can enormously increase the
activity of threshold doses of topical challengers.
For example, in the DHT-sensitized rat, dextran
does not cause calcification but if otherwise
ineffective amounts of FcC13 are injected sub-
cutaneously in dextran solution, severe topical
cutaneous calcinosis results. Unlike dextran,
egg white possesses considerable direct challeng-
ing potency, but if high dilutions of albumen (in
themselves almost ineffective) are subcutaneously
injected with subthreshold traces of FeCl3, the
result is again a greatly increased topical ealei-
phylactie response. Here, the dextran and egg
white apparently potentiate the action of iron,
somewhat as adjuvants can increase the efficiency
of antigens.
THE "CRITICAL PERIOD"
It is impossible to reproduce certain calci-
phylactie phenomena consistently without
strictly observing the critical period that must
elapse between treatment with sensitizer and
challenger. The length of this period is not the
same for all forms of calciphylactic responses;
indeed, we may obtain qualitatively different
reactions by merely altering the time interval
between treatment with sensitizer and challenger.
For example, if female rats weighing about 200 g.
are first given 1.5 mg. of DHT p.o. and 24 hours
later 1 ml. of ferric dextran, or "Fe-IDex" (—50
mg. Fe) i.p., they develop intense calcification
in the pancreas and retroperitoneal fat, but not
in the uterus. On the other hand, if the experi-
ment is repeated under otherwise identical con-
ditions except that now the Fe-Dex is given
24 hours before the DHT, the pancreas and
adipose tissue fail to react, while the uterus under-
goes intense calcification. Numerous other ex-
amples illustrating the decisive importance of
the critical period have been listed elsewhere
(9).
It is not yet clear how minor differences in the
timing of the treatment with sensitizer and
challenger can so radically change the form of a
calciphylactic response. In anaphylaxis, a rest
period after sensitization is necessary to allow
time for the formation of antibodies before the
challenging antigen is applied, but in ealciphy-
laxis we have no evidence of any antigen-anti-
body reaction. It may be argued that here, time
is required for the absorption of the sensitizer
and for the mobilization of calcium from the
bones. However, as we have said, some calci-
phylactic reactions are best elicited by simul-
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taneous treatment with sensitizer plus challenger
(e.g., the cardiovascular, renal and biliary-tract
lesions induced by DHT + Fe-CS, i.v.), whereas
others (e.g., uterine calcification after Fe-Dex,
i.p. + DHT) are most readily obtained after
pretreatment with the challenger. Of course, the
formation of a calcifiable matrix is also important.
The tissues that undergo calcification become
PAS-positive and the accumulation of PAS-tingi-
ble material may have to be adjusted to the
available calcium and phosphate before certain
forms of mineralization can develop.
In view of these facts, it is unlikely that the
time-lapse required for the development of any
one metabolic change could account for the
length of the critical period in all types of calci-
phylaxis.
DEVIATING CALCIPHYLAXIS
Exam ple.—If a rat (weighing 100—200 g.) is
given 50 mg. of iron intraperitoneally every
five days in the form of a readily diffusible iron
complex, such as Fe-Dex (ferric dextran*), it
develops a generalized hemosiderosis owing to
the formation of diffusely distributed, minute
iron deposits. In animals thus pretreated, the
most diverse forms of soft-tissue calcification are
inhibited. Topical treatment with direct calcifiers
no longer produces local calcification; heavy
overdosage with DHT or parathyroid hormone
fails to elicit the customary calcification in the
normally predisposed cardiovascular system,
kidney or lung; and calciphylactic responsiveness
to challengers is greatly diminished or totally
suppressed. Apparently, here, the diffuse impreg-
nation of the organism with a challenger results
in protection against the induction of large focal
calcium deposits.
DERMATOLOGIC IMPLICATIONS
It would be redundant to describe here all of
the cutaneous lesions that can be elicited in
animals by the calciphylactic technics, that have
been described in detail elsewhere (9). Suffice it to
mention a few experimentally induced calci-
phylactic changes of the skin, that are reminis-
cent of certain diseases of man. It must be
strongly emphasized, however, that the names
given to these experimental syndromes (e.g.,
* Available for example in the form of the trade
preparations Imferon®, Imposil®, of the Benger
Laboratories, London, England.
calciphylactic scieroderma, dermatomyositis or
psoriasis) are meant to serve only for identifica-
tion; they should not be considered to imply any
proven relationship to clinical entities that bear
similar designations.
Cutaneous calcinosis induced by topical chal-
lenge.—Following calciphylactic sensitization
(e.g., by DHT or parathyroid hormone), sub-
cutaneous injection of minute doses of chal-
lengers (e.g., a few micrograms of FeCI2, FeC13,
CeCl3, CrC1,, egg white or egg yolk) or even mere
plucking of the hair produces massive topical
calcium precipitation in the treated skin area. As
soon as 24 hours after challenge it is possible to
demonstrate histochemically (e.g., with the
AgNO3 technic) that the calcium deposits begin to
precipitate around collagen and elastic fibers in
the subcutis and cutis, often also effecting the hair
follicles, X-ray diffraction studies (kindly per-
formed by Dr. A. S. Posner of the National
Institutes of Health, Bethesda, Maryland)
revealed that in these deposits—as in the bones
and in pathologic soft-tissue calcifications of
man—the calcium occurs in the form of hydroxya-
patite crystals. Mild deposits of this type may
subsequently be absorbed, but heavy calcium
precipitates usually induce secondary inflam-
mation with sclerosis and often even necrosis
of the skin surface through which the calcified
tissue debris is eliminated. In all these respects
the experimentally induced lesions resemble
cutaneous calcinosis as it occurs in man.
Soft-tissue calcification is generally regarded
as a result of "decreased tissue vitality" second-
ary to chronic inflammation and necrosis. It
should be emphasized, therefore, that the calci-
phylactic challengers produce no demonstrable
tissue damage (as judged by the absence of
inflammation or necrosis) in the nonsensitized
organism and that even after sensitization calci-
fication precedes any histologically detectable
sign of tissue damage. Numerous observations
suggest that at least some types of injury may
predispose tissues to calcification under certain
conditions; yet, in view of the experimental ob-
servations just mentioned,, we must also admit
that the precipitation of endogenous calcium can
be the cause rather than the result of inflamma-
tion and necrosis.
The fact that nonspecific tissue damage is not
the decisive factor in the induction of calciphy-
lactic skin lesions is further substantiated by
a
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FIG. 1. Galciphylactic wheal with central "overchallenge." Circinate cutaneous calcinosis on margin
of skin patch infiltrated with 10% yolk. Central area remains unaffected.
other findings. If the skin of a sensitized animal
is treated with very heavy doses of chemical
challengers or intense mechanical trauma, calcifi-
cation occurs only in the form of circinate lesions
around the directly affected area and not in the
most severely damaged central tissue region
itself. (Fig. 1).
In their histologic structure, the calciphylac-
tically induced skin lesions are virtually indis-
tinguishable from cutaneous calcinosis and
scleroderma seen in man, but of course, this does
not prove an essential similarity in their evocative
pathogenetic mechanisms (Fig. 2 and 3).
It may be mentioned incidentally that, if
most of the body surface of a sensitized rat is
infiltrated with a challenger (e.g., egg white),
the entire challenged area undergoes calcification
with subsequent detachment of the resulting
hard "carapace". This phenomenon is reminiscent
of the molting or exuviation that normally occurs
in lower animals (e.g., crustaceans and snakes).
Normal molting is usually accompanied by a
considerable increase in the calcium content of
the affected skin, but here again, we wish to
point out that we have no proof of any participa-
tion of calciphylactic reactions in the mechanism
of physiologic molting. (Fig. 4).
Calciphylactic scleroderma with esophageal and
joint lesions.—In calciphylnctically sensitized
(e.g., DIIT-pretreated) rats the intravenous
injection of certain challengers, such as ferric
dextrin (Fe-Din) or Thorotrast®, elicits a syn-
drome reminiscent of calcifying scleroderma. It is
usually accompanied by severe esophageal lesions
and sometimes by calcareous bursitis (Figs.
5—7).
Although it is generally estimated that ap-
proximately 40% of the patients who suffer
from calcinosis universalis also exhibit mani-
festations of scleroderma, macroscopically visible
calcification is by no means a constant accom-
paniment of the latter disease in man. Neverthe-
less, some relationship between scleroderma and
calcium metabolism is suggested by the therapeu-
tic effect of calcium chelators in this as well as in
many other collagen diseases. Furthermore,
both calcifying scleroderma and esophageal
lesions due to systemic interventions are ex-
tremely rare and, hence, the association of such
changes both in clinical seleroderma and in
certain calciphylactic syndromes is noteworthy.
Therefore, it may be well to give serious attention
to the possibility that derangements in calcium
metabolism similar to those induced by calci-
phylaxis may play a role in scleroderma and
perhaps also in other related collagen diseases.
Psoriasiform calciphylaxis.—If following the
usual sensitization rats arc challenged by the
• •• ;••••
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Fin. 2. Topical cutaneous calcinosis produced by DHT + plucking of scalp hair. Rat sensitized with
DHT and challenged by plucking hair over scalp and back. Histologic appearance of typical calcified
skin wheal in epilated area. Calcium deposition is limited to subepithelial connective-tissue fibers of
sharply circumscribed region. (von Kóssa, X 120.)
Fin. 3. Various chronic forms of cutaneous calcinosis produced by DHT + epilation (hair plucking).
A: Borderline between healthy and scierosed skin during period of healing. In the affected region (below
arrow) there is dense connective tissue, but sebaceous glands are absent, hair follicles rare, and the epi-
dermis is thickened. (Fuchsin, X 23.) 13: Calcium is no longer visible in dense connective tissue of this
healing patch. Only few calcified granules remaining in foreign-body giant cells near upper left corner.(von Kóssa, X 65.)
:T•!•::7. •':
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Fin. 4. Cutaneous molt produced by DHT + albumen s.c. Rat (100 g. y): DHT (1 mg. p.o.) 1st day +
albumen (50%, 10 ml. s.c. infiltration of entire body surface, except head, ano-genital region and ex-
tremities) 2nd day; killed 25th day. Top: Complete circular skin carapace formed by cutaneous calcinosis
of infiltrated region (photographed 18th day). Bottom: Rat exuviates its old integument and emerges
with new skin on 24th day.
intraperitoneal injection of a single large dose of
Fe-Dex, there develops a chronic dermatosis
characterized by multiple reddish-brown, more
or less sharply demarcated, dry papules and
plaques covered by a thin layer of silvery scales.
The lesions are usually symmetrically distributed
on the back and thighs, often also affecting the
chest and scalp. During the initial stages there
may be widespread erythroderma with exfoliative
dermatitis. Even gentle removal of the scales
produces typical, slightly bleeding surface
patches, not unlike those of Auspitz' sign in
clinical psoriasis (Fig. 8). However, these ex-
perimental lesions differ fundamentally from true
psoriasis in that they are invariably accompanied
by more or less pronounced calcium precipitation
in the affected regions. Hence, in this case it is
particularly doubtful whether any relationship
exists between the experimental condition and
the clinical disease, which it resembles only
superficially.
Gal ci phylactic dermatomyositis.—Widespread
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FIG. 5. Cutaneous calcinosis of the face produced by DHT + Fe-Din i.v. Rat (110 g. 9): DHT (1 mg.
p.o.) 1st day + Fe-Din (1 ml. = 20mg. Fe, iv.) 2nd day; died 5th day. After shaving head and cutting
off right external ear at root, white calcium deposits become clearly visible in skin of snout, lips, eyelids
and their surroundings, as well as at root of external ear.
FIG. 6. Calcification of the tongue, pharynx and esophagus produced by DHT + Thorotrast® i.v. Rat(100g. 9): DHT (1 mg. p.o.) 1st day + (bottom) Thorotrast® (1 ml. iv.) 2nd day; killed 6th day. Pro-
nounced calcium deposition at root of tongue on both sides of glottis as well as along entire length of
esophagus except its most cranial portion. Top: Fresh. Bottom: AgNO3-stained specimen.
inflammation of the skin and muscles can be
elicited in DHT-sensitized rats if they are sub-
sequently given an intravenous injection of
Fe-Dex simultaneously with a subcutaneous
injection of a mastocyte discharger, such as
polymyxin or 48/80. Under these conditions,
there develops a symmetrical inflammatory
edema, particularly in the neck, affecting the
skin, the fascial layers of the nuchal muscles, and
the forelimb musculature. This inflammation is
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FIG. 7. Articular lesions produced by DHT + Thorotrast® iv. Rat (210 g. ): DHT (2 mg. p.o.) 1st
day + Thorotrast® (1 ml. iv.) 2nd day; killed 10th day. Left: Ring-shaped calcium deposition in and
around shoulder joint. Exposed head of humerus shows intact cartilage. Right: Opened shoulder joint
exposes subacromial bursa (arrow); white calcium deposits throughout joint region.
associated with calcium precipitation in varying
degrees as well as edema, hyalinization and frag-
mentation of muscle fibers. These changes are
reminiscent of the lesions that characterize
dermatomyositis in man, a disease that is like-
wise frequently associated with calcium precipita-
tion in the involved areas.
Histologic study of the skin and muscle regions
affected by calciphylactic dermatomyositis re-
veals that in this case the mastocytes play a
prominent pathogenetic role. Tinder the influence
of the histamine discharger, the mastocytes re-
lease their metachromatic granules, which sub-
sequently become impregnated with iron and
calcium salts. It is highly probable that here the
role of the metachromatic mastocyte material
is merely to attract the irritating calcium salts,
which then induce edema and inflammation.
This concept is further supported by the ob-
servation that pretreatment with mastocyte
dischargers prior to sensitization protects against
the subsequent induction of calciphylactic derma-
tomyositis by the usual procedure (Figs. 9 and
10).
Influence of deviating calciphylaxis upon the
skin—We have already mentioned the fact that
generalized impregnation of the connective
tissue, particularly the histiocyte system, with
granules of a challenger (e.g., Fe-Dex) can pro-
tect the organism against various forms of soft-
tissue calcification. For example, if a normal
(nonsensitized) rat receives repeated intraperi-
toneal injections of Fe-Dex, the iron compound
is rapidly absorbed from the peritoneum and
produces a general hemosiderosis, owing to the
deposition of iron particles not only in the re-
ticulo-endothelial system but also in the histio-
cytes, fibroblasts and to a lesser extent the col-
lagen fibers of the connective tissue throughout
the body. Rats thus pretreated become singularly
resistant not only to the various forms of calci-
phylaxis but also to the calcium precipitation
normally induced by the subcutaneous injection
of direct calcifiers or the generalized, predomi-
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FIG. 8. Calciphylactic psoriasis produced by DHT + Fe-Dex i.p. Rat (200 g. y): Fe-Dex (1 ml. =50
mg. Fe, i.p.) 1st day + DHT (2 mg. p.o.) 4th day; photographed 15th day. Left: Extensive nodular
calcium infiltration with marked scaling of skin. Scale removal (by gentle scratching along midline
over lumbar and sacral regions) caused diffuse surface bleeding corresponding to Auspitz' sign in pso
riasis. Right: Auspitz' sign in another similarly treated rat with less advanced lesions.
nantly vascular, cardiac and renal calcinosis that
is otherwise induced by acute overdosage with
vitamin-D derivatives or parathyroid hormone.
More recently my associate, Dr. Ralph Strebel,
and I observed that if rats are chronically treated
with very small doses of DHT, they do not tend
to show calcification in the cardiac muscle and
renal parenchyma, such as is elicited by heavy,
acute intoxication with the same compound;
instead, they develop a syndrome reminiscent of
progeria. Calcification occurs almost exclusively
in the arterial system, the cartilages of the ribs,
larynx and vocal cords. There is also kyphosis
with calcification of the intervertebral discs and
deformation of the vertebrae, intense catabolism,
loss of cutaneous elasticity with wrinkling of the
skin, loss of hair and discharge of cutaneous
mastocytes. The teeth tend to spread apart,
thereby causing malocclusion with erosion of the
enamel. Occasionally there is cataract formation.
All these lesions are strikingly similar to those
characteristic of advanced senility, but unlike
in the latter condition, they are not accompanied
by osteoporosis—on the contrary, the skeleton
becomes unusually sclerotic. Despite their bulk,
the affected bones are not particularly strong
and tend to be deformed by the stress of weight
bearing. In the course of bone reconstruction the
original Haversian lamellar pattern is destroyed
and replaced by random foci of newly formed
osseous tissue. Furthermore, narrow cement
lines can be seen between the original and newly
formed lamellar systems; these create a charac-
teristic "mosaic pattern," such as is typical of
osteitis deformans (Paget's disease).
It remains to be seen whether there is any
DERMATOLOGIC IMPLICATIONS OF STRESS AND CALCIPHYLAXIS 271
Fin. 9. Calciphylactic dermatomyositis produced by DHT + Fe-Dex iv. + PMX s.c. Two rats (100
g. ): DHT (1 mg. p.o.) 1st day + Fe-Dex (1 ml. 1 mg. Fe, iv.) 2nd day + (bottom) PMX (2 mg. in0.2 ml. water, s.c. in left flank region) 2nd day; killed 6th day. Top: Combined treatment with DHT
+ small dose of Fe-Dex produced no obvious macroscopically visible change. Bottom: Additional ad-
ministration of PMIX elicited particularly severe calciphylactic dermatomyositis, characterized by
thick infiltration of skin and by swelling of musculature, especially in head and neck regions.
relationship between this experimental disease
and progeria, true senility or osteitis deformans.
However, it is interesting, in any case, that all
the changes induced by this form of chronic
DHT intoxication can be completely prevented
by Fe-Dex. While all animals treated with DHT
alone eventually succumb, those that in addition
receive Fe-Dex survive in apparently perfect
health (Fig. 11).
Histologically, the skin of the rats treated
with DHT alone exhibits many changes charac-
teristic of senility. The surface epithelium, sebace-
ous glands, and the cutaneous muscles are
atrophic and the adipose tissue has virtually
disappeared. The collagenous connective tissue
appears to be shrunken and dense owing to the
practically total absorption of the fluid matrix
between the fibers. Particularly thick sheaths of
dense connective tissue are found around the
cutaneous nerves and, to a lesser extent, around
the arteries that are severely affected by Möncke-
berg sclerosis.
An especially striking feature of this lesion is
the nearly complete degranulation of all masto-
cytes throughout the cutis and subcutis. How-
ever, unlike following mastocyte depletion by
histamine-dischargers (e.g., polymyxin, 48/80),
the extruded metachromatic granules do not
disappear but remain in the connective tissue
between the fibers especially in the vicinity of
blood vessels. Here they form dense, perivascular
cuffs in and around the adventitia sometimes
apparently penetrating into the vascular wall.
By contrast in the animals protected by Fe-
Dcx, virtually all the cutaneous structures remain
normal, though heavily infiltrated by iron con-
taining phagocytes. Only one result of DHT-
overdosage is uninfluenced by Fe-Dex: the
discharge and perivascular accumulation of
mastocyte granules. Here the metachromatic
granules are frequently seen in close association
with iron particles around the blood vessels;
indeed sometimes both types of granules can be
identified within the body of the same cell.
The functional significance of this extraordi
narily pronounced accumulation of mastocyte
debris around the blood vessels remains to be
elucidated. However, since calcifiable tissue is
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FIG. 10. General appearance of the musculocutaneous lesions produced by DHT + Fe-Dex i.e. + PMX
s.c. Two rats: DHT + Fe-Dex + (All but A, left) PMX. A: Only animal on right shows lesions in and
around muscles of left front paw. B: Histologic appearance of severely affected skin after DHT +
PMX + Fe-Dex. Sealing with inflammation and calcification of derma. Liquefaction necrosis along
epithelial attachment and (left upper corner) within epithelium itself. (von Kóssa, X 95.) C: Edema,
hyalinization and fragmentation of muscle fibers in acute stage. (von Kóssa, X 95.) D and B: Nuclear
proliferation and inflammation in more advanced stage. Dark spots correspond to calcium deposits.
(von Kóssa, X 95.)
Figs. 1—10 after Selye (9). Courtesy of the University of Chicago Press
frequently metachromatie, it may well be asked
whether a perivaseular cuff of mastocyte granules
could not deviate calcium from the media where
it would otherwise form unabsorbable thick
plaques. If this interpretation were correct, the
accumulation of free mastocyte debris might
be looked upon as physiologic defence reaction,
which offers essentially the same kind of protec-
tion as Fe-Dex. Both the mast cell and the iron
particles could provide innumerable minute foci
of material which by virtue of its own calcium
affinity, could protect the adjacent vessels
against mineralization by successfully competing
with them for calcium. It is not incompatible
with this view that, of all the lesions induced by
DHT, only the accumulation of discharged
mastocyte granules fails to be prevented by
Fe-Dex prophylaxis since this particular change
does not appear to be a manifestation of damage
but of defence.
In this connection, it is noteworthy that intra-
venously injected India ink particles are nor-
mally deposited around free mastocyte granules
—for example, when mastocyte discharge is
produced by topical trauma or by treatment with
histamine discharging agents—while after DHT-
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FIG. 11. Prevention of DHT intoxication by Fe-Dex. A: General appearance of a rat that received
DHT only. Marked kyphosis. Pelvic bones and ribs visible through wrinkled, inelastic skin. B: Rat
treated with DHT + Fe-1)ex; essentially normal appearance. Both these rats were shaved for better
visualization of body. C: Aorta near arch, and F: left circumflex coronary artery of rat treated with
DHT alone shows intense calcinosis and distortion. D and F: Corresponding vessels of rat treated with
DHT and Fe-Dex are essentially normal, but adventitia contains many iron-storing (here dark) phago-
cytes and mast cells. (All sections von Kdssa, x 77.) [After Selye and Strebel (10), courtesy Proc. Soc.
Exper. Biol. & Med.]
treatment the mastocyte debris does not attract
carbon particles from the blood. It is possible—
though quite unproven—that in the latter ease
the jnastoeyte granules fail to attract carbon
because they are saturated with calcium. In any
event, if calcium is attracted by the granules, its
turnover must be very efficient, since no von-
Kossa-positive material is demonstrable on
them. It is equally possible, however, that the
perivaseular dispersion of ealeifiable metaehro-
matie material acts merely by preventing the
latter from being accumulated in the soft tissues
and bones where it could induce massive calcium
precipitation.
Some relationship between mastocyte granules
and calcification is also suggested by the pre-
viously cited observations on ealeiphylaetie
dermatomyositis. Here, von-Kóssa-positive cal-
cified material is histologically demonstrable
around mastocyte granules (9). Furthermore, the
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intense aggravation of DHT-induced arterial
calcification that can be induced by mastocyte
dischargers (8) might be ascribed to the destruc-
tion of mast cell granules and a consequent inac-
tivation of an important calcium deviating mech-
anism. Let me reemphasize, that none of these
concepts has as yet been proven; they are men-
tioned here only because they suggest promising
new experimental approaches to our problem.
SPECULATIONS CONCERNING POSSIBLE
INTERRELATIONS BETWEEN STRESS
AND CALCIPHYLAXIS
We still know very little about the basic
biochemical reactions regulating the LAS. and
G.A.S. (that is, the local and general adaptation
syndromes to stress), on the one hand, and the
local and systemic calciphylactic reactions, on
the other. Hence, it is possible to discuss the
interrelations between these two types of mech-
anisms in only the vaguest terms. Yet, it may
be opportune to compare these phenomena now,
since interesting connections appear to exist
between them.
Both the stress reactions and calciphylaxis
evolve primarily in the mesenchyma, especially
the connective tissue and the vascular system.
The principal changes elicited by the simplest
form of local stress are inflammation, hyaliniza-
tion and sclerosis. The "adaptive hormones,"
particularly the pro- and anti-inflammatory
corticoids, regulate the systemic response to
stress by increasing or decreasing the inflam-
matory potential. The "collagen diseases," which
are some of the most typical "diseases of adapta-
tion" are characterized by hyalinization of con-
nective tissue and vascular elements owing to
the deposition of PAS-positive material pre-
sumed to consist of mucopolysaccharides. Quite
similar changes can be produced in animals by
overdosage with the pro-inflammatory mineral-
ocorticoids (e.g., desoxycorticosterone, aldos-
terone).
The most striking feature of calciphylaxis is
the precipitation of calcium. However, this is
possible only after the formation of a calcifiable
matrix that is likewise PAS-positive and pre-
sumably rich in mucopolysaccharides. Here
again, the process gives rise to inflammation
with subsequent sclerosis.
Thus both the hyalinoses and calciphylaxis are
predominantly diseases of the mesenchyma.
Both the response to stress and calciphylaxis
are regulated by hormones and electrolytes.
The corticoids play a prominent role in stress,
especially through their influence upon extracellu-
lar sodium and chloride. Their manifold actions
appear to depend largely upon the regulation of
the equilibrium between intracellular potassium
and extracellular sodium.
In calciphylaxis the principal endogenous
stimulus i5 undoubtedly parathyroid hormone,
which regulates the metabolism of calcium and
phosphates. (Although vitamin-D derivatives
may also be synthesized in the body and thereby
contribute to the action of parathyroid hormone
through their essentially similar metabolic ac-
tions.)
Other hormones, especially ACTH and STH,
likewise exert an important influence upon
stress reactions and calciphylaxis, for example,
hypophysectomy interferes with both types of
reactivity. However, it would be premature to
analyze the participation of the entire endocrine
system in these reactions because the facts avail-
able are still too few.
The primary purpose (if the use of such a
teleologic term may be forgiven) of the L.A.S.
and G.A.S. is the induction of resistance against
local and systemic stress, respectively; stress
being defined as "the rate of wear and tear in a
biologic system during a given period of time"
(7).
On the other hand, calcification appears to be
intimately related to biologic (as opposed to
chronologic) aging: "the sum of all the wear and
tear suffered during life." It is not yet clear
whether derangements in calcium metabolism
are merely the results of aging or whether the
tissue changes characteristic of senility (degenera-
tion of connective tissue, atrophy of bones and
muscles, kyphosis, otosclerosis, senile cataracts,
arteriosclerosis, calcification of cartilages, de-
layed wound healing, diminished resistance to
stress, etc.) are, at least in part, consequences of a
primary disturbance in calcium metabolism. The
latter interpretation receives some support from
the experiments on deviating calciphylaxis,
in which interference with pathologic calcification
resulted in the prevention of all the changes
characteristic of aging, even those that are not
associated with manifest calcinosis.
Finally, some relationship between stress and
calciphylaxis is suggested by the observation
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that most calciphylwtic syndromes can be pre-
vented by previous exposure to stress (9)
The skin and the skeleton are the two principal
accumulations of connective tissue in the body,
the former being also the main reservoir of sodium
and chloride, the latter of calcium and phosphate.
It is not wholly unexpected, therefore, that both
the "diseases of adaptation" to stress and the
calciphylactic syndromes frequently affect the
skin, though skeletal participation is more com-
mon in the latter.
These concluding remarks are based on very
incomplete evidence; that is why we entitled
them "speculations." However, we feel that a
sufficient number of objective observations has
now been made regarding the responses of the
skin to stress and calciphylaxis to justify an
interim report of this kind before your Society.
I am firmly convinced that further progress
along these lines will depend largely upon the
clinical evaluation of these first tentative efforts
toward the creation of an Experimental Der-
matology as a systematized branch of your
science.
SUMMARY
Following a brief outline of the concepts of
stress and calciphylaxis, a number of cutaneous
calciphylactic syndromes were described.
Calciphylaxis is a condition of induced hyper-
sensitivity in which tissues respond to appropriate
challenging agents with local calcification. We
distinguish a focal form, in which calcium pre-
cipitation is concentrated in a circumscribed
area, from a deviating form of calciphylaxis,
which, by contrast, prevents focal tissue calci-
fication, presumably by distributing the metal
evenly in the organism and thereby preparing it
for excretion.
Finally, special attention has been given to
the relationship between calcification and aging.
Through the induction of diffuse calciphylaxis it
became possible to prevent the development of
many experimental organ lesions characteristic
of senility.
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